A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
about
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patientsRoutine versus selective antifungal administration for control of fungal infections in patients with cancerInterventions for preventing oral candidiasis for patients with cancer receiving treatmentTherapeutic Drug Monitoring of Posaconazole: an UpdatePrevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazoleTreatment and prophylaxis of invasive candidiasisMicafungin: an evidence-based review of its place in therapyAntifungal Therapy in Hematopoietic Stem Cell Transplant RecipientsHigh-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infectionsIn vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and CandidaDouble-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patientsGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveProphylactic Measures During Induction for Acute Myeloid Leukemia.Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer.Impact of an intravenous fluconazole restriction policy on patient outcomes.Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.Lipid-based amphotericin B for the treatment of fungal infections.Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.Panfungal PCR assay for detection of fungal infection in human blood specimens.Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center.Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents.Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantationVoriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review.Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts.Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.Fungal infections in transplant and oncology patients.Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.Routine versus selective antifungal administration for control of fungal infections in patients with cancer.Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.Rapid identification of fungi by using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system.Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.
P2860
Q24193785-9B9F27AE-8C96-4787-ACA6-C820658A190FQ24193817-D8F811AC-C769-40CB-96E5-29FB0C7CA88CQ24243005-9A4839AA-2086-4ABA-82D1-CD152617BE3DQ26746016-3B17F6F2-188E-411E-8A3C-705AE9F94C10Q26782472-5DE34A9C-30BE-4647-99C1-1AF3BB1FDC7BQ27001567-7DE262AF-AC1F-45F0-A20F-67061D6ED44BQ27014780-D8E04EAA-04AE-4BE3-8274-B3037B1A71ECQ28080147-AA1CB95E-7211-4BB2-92F2-F1770E26A7BCQ28292927-0AF0F7D4-E980-4C77-BC49-CD0F5F81B23CQ28344464-520229B2-94C9-41A3-90DC-A0795E3F3D23Q28362691-EE0BDE96-E320-4C35-AEF0-9355DC8C147BQ28388806-F820EABB-AE15-420E-AEF9-26A007E6EDFEQ30235496-C77D617F-4B82-4A09-9775-BC5C702E96A9Q30596268-273A9B1C-940C-439F-A510-DAF102D678B4Q30887333-FE582DB3-73B0-49C3-9B78-C8074D3F60F9Q31372000-9A9936C0-E8DB-48D9-B938-436C8F81CDAEQ31893406-111A582A-B113-4526-9979-B051C8267315Q31954098-8321BDC7-CFC0-4918-9A94-1914C34C476AQ31989784-7C61F7B2-9B0C-4762-BCC6-B012FC7DF165Q33340528-C9E224D1-1065-4FC3-98C6-24F1A2CBE077Q33559503-755136D9-37AF-4DF8-9EA4-7FEDF5DE28F8Q33604227-296A639E-3AB3-4517-932C-B67E0F3DC3C1Q33608832-89D7111F-C347-446C-AF38-7E6AC154DC0FQ33665050-2C310AC4-A2C3-4EF7-8D82-6FB392D7EE18Q33691981-5E0623DB-E61C-4A9C-BE72-E686BA19DF6FQ33699122-DB613FA8-0F0D-4808-9899-D44731DEAF35Q33721804-E648FC02-3C5C-4FF0-A8EF-C02FB4F8751BQ33726292-C95AE74E-6194-4AEF-8953-921F510B022DQ33751366-62DFACA7-C87E-44AC-940B-3308590300B3Q33774641-C6525EE0-65C6-49A9-A407-C3845E433D58Q33788619-7A9B2982-9E8C-4611-8E21-F2468C8F1332Q33879950-32C5D0FF-8F36-4AB7-BD5D-010312BB16ACQ33894467-AACF44F7-EA80-4B9B-876D-F9B883D4AFB7Q33896940-1C1233C1-E2ED-42BC-A9BD-CBB9251B101DQ33898397-44047B3C-0AC4-44ED-91FC-BB7D1092BFF2Q33909375-02FC5A9C-8D86-44E9-82FF-A03C5EC68EADQ33959121-382899AC-D4D9-4101-99FC-B715EA55A357Q33960875-E690067A-78E6-4BC2-87E0-7A64CAA2034FQ33964121-2030076C-B26D-4093-88F9-CC59747A8FFBQ33977578-A6F1F72C-EA0A-4ED8-B09A-AAABC9EF6013
P2860
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
A controlled trial of fluconaz ...... g bone marrow transplantation.
@en
A controlled trial of fluconaz ...... g bone marrow transplantation.
@nl
type
label
A controlled trial of fluconaz ...... g bone marrow transplantation.
@en
A controlled trial of fluconaz ...... g bone marrow transplantation.
@nl
prefLabel
A controlled trial of fluconaz ...... g bone marrow transplantation.
@en
A controlled trial of fluconaz ...... g bone marrow transplantation.
@nl
P2093
P1476
A controlled trial of fluconaz ...... g bone marrow transplantation.
@en
P2093
Chandrasekar PH
Friedman DJ
Goodman JL
Greenfield RA
Shadduck RK
Winston DJ
P304
P356
10.1056/NEJM199203263261301
P407
P577
1992-03-01T00:00:00Z